文献速递糖尿病肥胖与代谢综合征

卵泡抑素样蛋白1作为与胰岛素抵抗和体力活动相关的新型脂肪肌因子

Follistatin-like 1 as a Novel Adipomyokine Related to Insulin Resistance and Physical Activity.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

研究探讨循环FSTL-1水平与2型糖尿病胰岛素抵抗的关系及其调控因素。在db/db小鼠中脂肪组织FSTL-1蛋白表达升高,298例T2DM患者和202例健康对照的血清FSTL-1水平在T2DM及超重/肥胖者中升高,并与HOMA-IR、脂联素及肥胖代谢参数相关。45分钟体力活动可显著升高健康年轻人循环FSTL-1,而高胰岛素钳夹和脂质输注升高FFA则使其下降。

要点

  • T2DM及超重/肥胖者循环FSTL-1水平升高,与HOMA-IR和脂联素相关。
  • 45分钟体力活动可显著升高健康年轻人循环FSTL-1浓度。
  • 高胰岛素血症和急性FFA升高可显著降低循环FSTL-1水平。

核心结论

  • FSTL-1可能是与胰岛素抵抗和体力活动相关的脂肪肌因子,T2DM患者循环FSTL-1水平升高。

研究设计与样本

  • 动物实验检测C57BL/6J和db/db小鼠FSTL-1表达,并用ELISA测定298例T2DM患者和202例健康对照的血清FSTL-1水平。
  • 干预研究观察口服葡萄糖耐量试验、高胰岛素正葡萄糖钳夹、脂质输注、急性运动和冷暴露试验中循环FSTL-1水平变化。

主要发现

  • db/db小鼠脂肪组织FSTL-1蛋白表达显著高于野生型小鼠。
  • T2DM和超重/肥胖参与者循环FSTL-1水平高于健康和瘦个体,且与HOMA-IR、脂联素及肥胖和代谢相关参数相关。
  • 45分钟体力活动显著增加年轻健康参与者循环FSTL-1浓度,小鼠脂肪组织FSTL-1蛋白表达在体力活动后显著升高。
  • 高胰岛素正葡萄糖钳夹期间的高胰岛素血症和脂质输注诱导的急性FFA升高导致循环FSTL-1水平显著下降。
  • 口服葡萄糖挑战或冷暴露试验后循环FSTL-1水平无变化。

临床怎么用

  • 循环FSTL-1可作为反映胰岛素抵抗和体力活动状态的潜在脂肪肌因子标志物。
  • 评估T2DM患者代谢状态时可关注FSTL-1与HOMA-IR、脂联素的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Follistatin-like protein-1 (FSTL-1) is considered to be an adipokine or myokine that could be a potential regulator of metabolism. Our purpose is to investigate the relationship between circulating FSTL-1 levels and insulin resistance (IR) in type 2 diabetes mellitus (T2DM) and to identify the regulatory factors. METHODS: FSTL-1 expression in C57BL/6J and db/db mice was examined by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and Western blots. Serum FSTL-1 levels were measured by enzyme-linked immunosorbent assay in 298 T2DM patients and 202 healthy controls. Changes in the circulating FSTL-1 level were observed during the oral glucose tolerance test, EHC (euglycemic-hyperinsulinemic clamp), lipid infusion, acute exercise, and cold-exposure test. RESULTS: We found that FSTL-1 protein expression in the adipose tissue of db/db mice was significantly higher than that of wild-type mice. Importantly, circulating FSTL-1 levels in T2DM and overweight/obese participants were higher than those in healthy and lean individuals, and was related to HOMA-IR, adiponectin, and obesity- and metabolism-related parameters. In the intervention study, 45 minutes of physical activity was found to significantly increase the circulating FSTL-1 concentration in young, healthy participants. Further, FSTL-1 protein expression in adipose tissue rose dramatically in response to physical activity in mice. Hyperinsulinemia during EHC and acute elevated FFA induced by lipid infusion resulted in a significant decrease in the circulating FSTL-1 levels. However, no change was found in the circulating FSTL-1 levels in response to the oral glucose challenge or cold-exposure test. CONCLUSIONS: FSTL-1 may be an adipomyokine associated with insulin resistance and physical activity, and circulating FSTL-1 levels are increased in patients with T2DM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Xu X, Zhang T, Mokou M, et al. Follistatin-like 1 as a Novel Adipomyokine Related to Insulin Resistance and Physical Activity. J Clin Endocrinol Metab. 2020. PMID: 32894773. doi:10.1210/clinem/dgaa629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。